| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $99.7M | $47.4M | $127.0M |
| YoY Revenue Growth % | +110.5% | -62.7% | — |
| Gross Profit | -$880.0K | -$12.6M | — |
| Gross Margin % | -0.9% | -26.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$35.4M | -$52.8M | -$50.8M |
| Operating Margin % | -35.5% | -80.0% | -40.0% |
| Net Income (GAAP) | -$79.6M | -$48.6M | -$50.3M |
| EBITDA (Normalized) | -$34.5M | -$51.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$33.4M | -$34.7M | -$52.7M |
| Capital Expenditures (CapEx) | $1.1M | $1.6M | — |
| Free Cash Flow (FCF) | -$34.6M | -$36.3M | -$52.7M |
| FCF Margin % | -34.7% | -76.7% | -41.5% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $21.1M | $11.2M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | -$43.0M | $19.0M | — |